Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Schwinger · SciRah

Researcher profile · Semantic Scholar

R. Schwinger

Share profile

R. Schwinger — researcher profile on SciRah

h-index: 59
Works: 452
Citations: 12K

Most-cited papers

Timing of Active Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation Therapy.
B. Schrage, J. Sundermeyer, S. Blankenberg, P. Colson +32 more
2022JACC. Heart failure92 citations Open access
Semantic Scholar
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
A. Bauer, M. Schreinlechner, N. Sappler, T. Dolejsi +110 more
2021The Lancet Respiratory Medicine78 citations Open access
Semantic Scholar
Use of mechanical circulatory support in patients with non‐ischaemic cardiogenic shock
B. Schrage, J. Sundermeyer, B. Beer, L. Bertoldi +39 more
2023European Journal of Heart Failure41 citations Open access
Semantic Scholar
Clinical presentation, shock severity and mortality in patients with de novo versus acute‐on‐chronic heart failure‐related cardiogenic shock
J. Sundermeyer, C. Kellner, B. Beer, L. Besch +42 more
2023European Journal of Heart Failure31 citations Open access
Semantic Scholar
Telemedical cardiac risk assessment by implantable cardiac monitors in patients after myocardial infarction with autonomic dysfunction (SMART-MI-DZHK9): a prospective investigator-initiated, randomised, multicentre, open-label, diagnostic trial.
A. Bauer, N. Sappler, L. von Stuelpnagel, M. Klemm +35 more
2022The Lancet Digital Health25 citations Open access
Semantic Scholar
Management of high-risk acute pulmonary embolism: an emulated target trial analysis
A. Stadlbauer, Tom Verbelen, L. Binzenhöfer, Tomaz Goslar +84 more
2025Intensive Care Medicine23 citations Open access
Semantic Scholar
Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort study.
B. Beer, C. Kellner, A. Gossling, J. Sundermeyer +37 more
2023European heart journal. Acute cardiovascular care15 citations
Semantic Scholar
Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock
J. Sundermeyer, C. Kellner, B. Beer, L. Besch +41 more
2023Clinical Research in Cardiology14 citations Open access
Semantic Scholar
Fulminant myocarditis: outcome predictors in an international cohort study.
N. Majunke, F. Haertel, L. Binzenhöfer, N. Fischer +54 more
2025European Heart Journal11 citations
Semantic Scholar
Incidence and predictors of weaning failure from veno‐arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shock
A. Dettling, C. Kellner, J. Sundermeyer, B. Beer +35 more
2025European Journal of Heart Failure10 citations Open access
Semantic Scholar
Kidney injury in patients with heart failure‐related cardiogenic shock: Results from an international, multicentre cohort study
J. Sundermeyer, C. Kellner, B. Beer, L. Besch +38 more
2025European Journal of Heart Failure10 citations Open access
Semantic Scholar
Sex-related differences in patients presenting with heart failure–related cardiogenic shock
J. Sundermeyer, C. Kellner, B. Beer, L. Besch +40 more
2024Clinical Research in Cardiology6 citations Open access
Semantic Scholar
Repetitive Therapie mit Levosimendan reduziert NT-proBNP und verbessert NYHA-Klasse
Max Wechsler, R. Schwinger
2022Aktuelle Kardiologie5 citations
Semantic Scholar
Heterotopic Transcatheter Tricuspid Valve Replacement in a Patient With Carcinoid Heart Disease
L. Stolz, P. Doldi, L. Weckbach, R. Schwinger +4 more
2022JACC Case Reports4 citations Open access
Semantic Scholar
Balancing blood pressure and catecholamine support is critical in heart failure-related cardiogenic shock patients.
B. Beer, C. Kellner, J. Sundermeyer, L. Besch +19 more
2026European Journal of Heart Failure2 citations
Semantic Scholar
Troponin predicts mortality in heart failure-related cardiogenic shock.
B. Beer, J. Sundermeyer, L. Besch, A. Dettling +30 more
2025Internal and Emergency Medicine2 citations Open access
Semantic Scholar
Prehospital thrombolytic treatment of high-risk acute pulmonary embolism
Hugo Lanz, L. Binzenhöfer, Tom Verbelen, A. Stadlbauer +78 more
2025Critical Care2 citations Open access
Semantic Scholar
Sekundärprävention bei KHK: Was ist unerlässlich?
R. Schwinger
2023MMW, Fortschritte der Medizin2 citations
Semantic Scholar
Medikamentöse Therapie der Herzinsuffizienz
R. Schwinger
2024MMW, Fortschritte der Medizin1 citations
Semantic Scholar
Association of Repetitive Dosing of Levosimendan with Reduction of NYHA Class and NT-proBNP Levels in Decompensated Heart Failure: A Retrospective Cohort Study
Max Wechsler, R. Schwinger
2022Drugs - Real World Outcomes1 citations Open access
Semantic Scholar
Einsatz eines ECLS bei Patienten im kardiogenen und septischen Schock: Untersuchung zur Indikation und zum Outcome
Lukas Wechsler, Johannes Heigl, H. Machann, Sabine Witt +1 more
2020Aktuelle Kardiologie1 citations
Semantic Scholar
Risiko: Clot in Transition
R. Schwinger
2026CardioVasc0 citations
Semantic Scholar
Abwarten ist keine Option
R. Schwinger, Jan Kropáček, E. Bösl
2026CardioVasc0 citations
Semantic Scholar
Stabile HFrEF: Vericiguat wohl ohne Nutzen
R. Schwinger
2026MMW - Fortschritte der Medizin0 citations
Semantic Scholar
PCI im stenosierten Bypass weniger risikoreich als im Nativgefäß
R. Schwinger
2026CardioVasc0 citations
Semantic Scholar
Vorhofflimmern: Verschluss oder Antikoagulation?
R. Schwinger
2026CardioVasc0 citations
Semantic Scholar
Tirzepatid und Dulaglutid im Direktvergleich
R. Schwinger
2026MMW, Fortschritte der Medizin0 citations
Semantic Scholar
Herzblock bei jungem Patienten: Lyme-Karditis?
R. Schwinger, Jan Kropáček
2026CardioVasc0 citations
Semantic Scholar
LV-Unloading bei hochgradig eingeschränkter Pumpfunktion und Hochrisiko-PCI ohne Nutzen
R. Schwinger
2026CardioVasc0 citations
Semantic Scholar
Gewicht: Tirzepatid schlägt Semaglutid
R. Schwinger
2026MMW - Fortschritte der Medizin0 citations
Semantic Scholar
Erhaltene Pumpfunktion spricht gegen Betablocker
R. Schwinger
2026MMW - Fortschritte der Medizin0 citations
Semantic Scholar
Nach Myokardinfarkt: Betablocker bei erhaltener Pumpfunktion ohne Nutzen
R. Schwinger
2026CardioVasc0 citations
Semantic Scholar
Signifikant weniger kardiovaskuläre Ereignisse bei einem LDL-Cholesterin-Zielwert unter 55 mg/dl
R. Schwinger
2026CardioVasc0 citations
Semantic Scholar
Conduction System Pacing und biventrikuläre Stimulation im Vergleich
R. Schwinger
2026CardioVasc0 citations
Semantic Scholar
Mikroaxialpumpe ohne Nutzen bei stabilem STEMI
R. Schwinger
2026CardioVasc0 citations
Semantic Scholar
Bradykarde Herzrhythmusstörungen im EKG
R. Schwinger
2026CME0 citations
Semantic Scholar
Tirzepatid versus Dulaglutid bei Diabetes und erhöhtem kardiovaskulärem Risiko
R. Schwinger
2026CardioVasc0 citations
Semantic Scholar
PCI am besten im stenosierten Bypass
R. Schwinger
2026MMW - Fortschritte der Medizin0 citations
Semantic Scholar
Dyspnoe im Erwachsenenalter
R. Schwinger, Jan Kropáček
2026CardioVasc0 citations
Semantic Scholar
Akutes Koronarsyndrom nach Bypass-Operation
R. Schwinger, Mohamed Eltarahony, Jan Kropáček
2026CardioVasc0 citations
Semantic Scholar
Doppelt gut: Finerenon und Empagliflozin
R. Schwinger
2025MMW - Fortschritte der Medizin0 citations
Semantic Scholar
Paroxysmales Vorhofflimmern: Pulsed-Field-Ablation und Kryoballon im Vergleich
R. Schwinger
2025CardioVasc0 citations
Semantic Scholar
Leistungsminderung bei Belastung
E. Bösl, Jan Kropáček, R. Schwinger
2025CardioVasc0 citations
Semantic Scholar
Weitere Option bei HFpEF und Adipositas
R. Schwinger
2025CardioVasc0 citations
Semantic Scholar
HFrEF: Optimale medikamentöse Therapie kann Defi ersparen
R. Schwinger
2025MMW - Fortschritte der Medizin0 citations
Semantic Scholar
Chronische Nierenerkrankung und Diabetes: Kombinationstherapie mit additiven Effekten
R. Schwinger
2025CardioVasc0 citations
Semantic Scholar
Thrombektomie: PAP sinkt, RV-Funktion verbessert
R. Schwinger, Jan Kropáček
2025CardioVasc0 citations
Semantic Scholar
Stärkere Gewichtsreduktion durch Cagrilintid plus Semaglutid
R. Schwinger
2025CardioVasc0 citations
Semantic Scholar
Finerenon wirksam bei Herzinsuffizienz mit mäßig reduzierter oder erhaltener Pumpfunktion
R. Schwinger
2025CardioVasc0 citations
Semantic Scholar
Finerenon wirkt bei Herzinsuffizienz
R. Schwinger
2025MMW - Fortschritte der Medizin0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Schrage×13
Invite
B. Schrage — researcher profile on SciRah
N. Mangner×12
Invite
N. Mangner — researcher profile on SciRah
B. Beer×12
Invite
B. Beer — researcher profile on SciRah
T. Graf×11
Invite
T. Graf — researcher profile on SciRah

×10

Invite

J. Sundermeyer — researcher profile on SciRah

E. Lüsebrink×10

Invite

E. Lüsebrink — researcher profile on SciRah

Invite

N. Majunke — researcher profile on SciRah

Invite

P. Nordbeck — researcher profile on SciRah

Invite

L. Besch — researcher profile on SciRah

Invite

A. Dettling — researcher profile on SciRah

F. Pappalardo×9

Invite

F. Pappalardo — researcher profile on SciRah

Invite

C. Scherer — researcher profile on SciRah